Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR

Research output: Contribution to journalArticle

Abstract

Background: The t(6;9)(p23;q34) chromosomal translocation is found in 1% of acute myeloid leukemia and encodes the fusion protein DEK-NUP214 (formerly DEK-CAN) with largely uncharacterized functions. Methods: We expressed DEK-NUP214 in the myeloid cell lines U937 and PL-21 and studied the effects on cellular functions. Results: In this study, we demonstrate that expression of DEK-NUP214 increases cellular proliferation. Western blot analysis revealed elevated levels of one of the key proteins regulating proliferation, the mechanistic target of rapamycin, mTOR. This conferred increased mTORC1 but not mTORC2 activity, as determined by the phosphorylation of their substrates, p70 S6 kinase and Akt. The functional importance of the mTOR upregulation was determined by assaying the downstream cellular processes; protein synthesis and glucose metabolism. A global translation assay revealed a substantial increase in the translation rate and a metabolic assay detected a shift from glycolysis to oxidative phosphorylation, as determined by a reduction in lactate production without a concomitant decrease in glucose consumption. Both these effects are in concordance with increased mTORC1 activity. Treatment with the mTORC1 inhibitor everolimus (RAD001) selectively reversed the DEK-NUP214-induced proliferation, demonstrating that the effect is mTOR-dependent. Conclusions: Our study shows that the DEK-NUP214 fusion gene increases proliferation by upregulation of mTOR, suggesting that patients with leukemias carrying DEK-NUP214 may benefit from treatment with mTOR inhibitors.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology

Keywords

  • Acute myeloid leukemia, DEK-NUP214, DEK-CAN, Fusion gene, Proliferation, mTOR, Everolimus
Original languageEnglish
Article number440
JournalBMC Cancer
Volume13
Publication statusPublished - 2013
Publication categoryResearch
Peer-reviewedYes

Total downloads

No data available

Related research output

Carl Sandén, 2014, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University. 66 p.

Research output: ThesisDoctoral Thesis (compilation)

View all (1)